Tus kws kho mob
QP86-20 Medical Drug Update for New to Market Tanezumab
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 09, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2061 - 2070 ntawm 4204
Tus kws kho mob
QP85-20 Commercial Pharmacy Benefit Exclusion for Tecartus™
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 09, 2020
Tus kws kho mob
QP88-20 Commercial Pharmacy Benefit Exclusion for Viltepso®
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 09, 2020
Tus kws kho mob
P71-20 Minnesota Health Care Programs Reimbursement Policy Update for Modifier 78
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
2020 September Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P50R1-20 Update: eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment (DME), Home Health Care (HHC), and Post-Acute Care (PAC) Services for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P65-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P70-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective November 2, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P67-20 Radiation Oncology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P69-20 Update Early Intensive Developmental and Behavioral Intervention (EIDBI) Authorization Process
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020